BXP fundamentals
An in-depth look to BEXIMCO PHARMACEUTICALS SPON GDR REP ONE ORD SH OF TAKA 10 REG S operating, investing, and financing activities
BXP free cash flow for Q3 24 is 12.29 M GBP. For 2023, BXP free cash flow was 29.65 M GBP and operating cash flow was 49.09 M GBP.
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: GBP
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM